↓ Skip to main content

Influence of subcutaneous specific immunotherapy on drug costs in children sufferingfrom allergic asthma

Overview of attention for article published in Clinical and Translational Allergy, September 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Influence of subcutaneous specific immunotherapy on drug costs in children sufferingfrom allergic asthma
Published in
Clinical and Translational Allergy, September 2013
DOI 10.1186/2045-7022-3-30
Pubmed ID
Authors

Thomas Reinhold, Julia Ostermann, Susanne Thum-Oltmer, Bernd Brüggenjürgen

Abstract

Subcutaneous specific immunotherapy (SCIT) is an effective treatment attenuating the progression of allergic asthma. To date, there is a lack of studies investigating the economic consequences of SCIT on health care expenditures.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 5%
Unknown 21 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 27%
Other 4 18%
Student > Master 3 14%
Unspecified 2 9%
Student > Bachelor 2 9%
Other 4 18%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 13 59%
Unspecified 2 9%
Nursing and Health Professions 2 9%
Environmental Science 1 5%
Unknown 4 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2013.
All research outputs
#15,169,543
of 25,374,647 outputs
Outputs from Clinical and Translational Allergy
#519
of 756 outputs
Outputs of similar age
#112,990
of 208,970 outputs
Outputs of similar age from Clinical and Translational Allergy
#16
of 22 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 756 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 208,970 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.